ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients

Several studies have evaluated the efficacy of neoadjuvant treatment using oxaliplatin and fluoropyrimidines in advanced gastric cancer (GC). However, preoperative biomarkers predictive of clinical outcome remain lacking. We examined polymorphisms in the MTHFR, DPYD, UMPS, ABCB1, ABCC2, GSTP1, ERCC1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Li, Ziyu, Xing, Xiaofang, Shan, Fei, Li, Shuangxi, Li, Zhongwu, Xiao, Aitang, Xing, Zhaodong, Xue, Kan, Li, Zhemin, Hu, Ying, Jia, Yongning, Miao, Rulin, Zhang, Lianhai, Bu, Zhaode, Wu, Aiwen, Ji, Jiafu
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342428/
https://ncbi.nlm.nih.gov/pubmed/27487151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10961
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars